Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can rewards help beat stimulant addiction? new study tests Clinic-Wide approach

NCT ID NCT05702021

Knowledge-focused Sponsor: Northwestern University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a special training and support program can help addiction clinics start using contingency management, a proven method that gives rewards to patients who stay off stimulants. Researchers will work with 76 clinics and track how many patients and counselors use the program. The goal is to see if this approach can bridge the gap between research and real-world practice.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
contingency management (a behavioral intervention that provides incentives for staying drug-free)
What this could lead to
If successful, this could show how to effectively implement contingency management in addiction clinics, potentially improving stimulant use treatment on a wider scale.
What could go wrong
This is an implementation study, not a test of the treatment itself. It focuses on clinic processes, so direct patient benefits may be limited or take time to appear.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 76 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2023

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* Opioid Treatment Program Counselors: * Inclusion criteria: 1) provide ongoing psychosocial support to medication for opioid use disorder patients (e.g., intake sessions, individual counseling, and/or group counseling sessions), and 2) have an active caseload * Exclusion criteria: Younger than 18 years of age, unable to provide informed consent * Persons on Medication for Opioid Use Disorder \[Not recruited, via electronic medical records only\] * Inclusion criteria: must be newly initiated on medication for opioid use disorders (within the past 30 days) and have concurrent stimulant use (indicated by self-report of past 30-day stimulant use or positive toxicology screen within 30 days). * Exclusion criteria: Younger than 18 years of age, Does not have electronic medical records

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stimulant use (diagnosis) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease opiate dependence substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stimulant use (diagnosis)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ACCESS Community Health Networks

    RECRUITING

    Chicago, Illinois, 60609, United States

  • Addiction Recovery Institute

    COMPLETED

    Pawtucket, Rhode Island, 02860, United States

  • CODAC

    COMPLETED

    Providence, Rhode Island, 02909, United States

  • Community Outreach Intervention Projects

    RECRUITING

    Chicago, Illinois, 60654, United States

  • Comprehensive Treatment Centers

    COMPLETED

    Providence, Rhode Island, 02905, United States

  • Family Guidance Centers

    RECRUITING

    Chicago, Illinois, 60654, United States

  • Healthcare Alternative Systems

    COMPLETED

    Chicago, Illinois, 60651, United States

  • Lawndale Christian Health Center

    COMPLETED

    Chicago, Illinois, 60623, United States

  • Rosecrance Health Network

    RECRUITING

    Rockford, Illinois, 61108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.